Eraloner 50 Mg 20 Tablets

Eraloner 50 Mg 20 Tablets

Description:

Eraloner 50 mg 20 tablets is a prescription cardiovascular medicine containing eplerenone, a selective aldosterone (mineralocorticoid) receptor antagonist. It is primarily used as an adjunct therapy in the management of chronic heart failure and certain types of hypertension, especially in patients with left ventricular dysfunction or following myocardial infarction. By blocking the effects of aldosterone in the renin-angiotensin-aldosterone system (RAAS), Eraloner helps reduce fluid retention, lower blood pressure, and decrease the risk of cardiovascular complications when used under medical supervision.

Indications:

• Treatment of chronic heart failure (usually NYHA class II–IV) in adults, particularly with reduced ejection fraction, as part of standard therapy.
• Management of left ventricular dysfunction following a recent myocardial infarction, in addition to standard post-MI therapy, to reduce cardiovascular risk (as directed by a cardiologist).
• Adjunct treatment for certain patients with hypertension where a mineralocorticoid receptor antagonist is indicated (only under specialist supervision).
• Helps reduce signs and symptoms associated with fluid overload such as edema, shortness of breath, and fatigue related to heart failure.

Active Ingredients / Key Components:

• Eplerenone – 50 mg per film-coated tablet.
• Excipients: The full list of inactive ingredients (excipients, colorants, preservatives) is not available in the provided information. Please refer to the official package leaflet for a complete excipient list.

Dosage & Administration / How to Use:

• Use only as prescribed by a physician experienced in the management of heart failure or cardiovascular diseases.
• Typical adult dosing for heart failure or post-myocardial infarction is usually initiated at a lower dose (for example 25 mg once daily) and may be titrated up to 50 mg once daily or 50 mg twice daily based on clinical response, kidney function, and serum potassium levels. The exact regimen must be determined by your doctor.
• Tablets should be swallowed whole with a glass of water and should not be crushed or chewed.
• Can be taken with or without food, but it is advisable to take it at the same time each day for consistent blood levels.
• Regular monitoring of serum potassium and kidney function (serum creatinine, eGFR) is essential before starting therapy, during dose adjustments, and periodically thereafter.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Do not stop taking Eraloner suddenly without consulting your doctor, as this may worsen your heart condition or blood pressure control.

Clinical Benefits:

• Helps reduce morbidity and mortality in selected patients with chronic heart failure or left ventricular dysfunction following myocardial infarction, when used as part of guideline-directed therapy.
• Blocks aldosterone at mineralocorticoid receptors, decreasing sodium and water retention and helping to reduce edema and congestion in heart failure.
• Supports better blood pressure control in appropriate patients by promoting mild diuresis and reducing vascular and cardiac remodeling driven by aldosterone.
• May improve exercise tolerance, reduce hospitalizations for heart failure, and enhance overall quality of life when used regularly under medical supervision.

Warnings & Contraindications:

• Contraindicated in patients with severe kidney impairment, anuria, or clinically significant hyperkalemia (high serum potassium), or in those taking strong CYP3A4 inhibitors (such as certain antifungals or antivirals), unless specifically allowed by a specialist.
• Use with extreme caution in patients with moderate kidney dysfunction, diabetes with kidney disease, or those taking other medications that increase potassium (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics, potassium supplements).
• Not recommended in patients with Addison’s disease or other conditions associated with high potassium levels.
• Regular monitoring of serum potassium and renal function is mandatory before and during therapy to avoid serious electrolyte disturbances.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Eplerenone should only be used in pregnancy or lactation if clearly needed and under strict medical supervision.
• Inform your doctor about all other medicines you are taking, including over-the-counter products, herbal supplements, and salt substitutes containing potassium, to avoid dangerous interactions.
• May cause dizziness or lightheadedness, especially at the start of treatment or when combined with other blood pressure-lowering agents. Use caution when driving or operating machinery until you know how the medicine affects you.
• Consult your doctor before use if you have liver disease, dehydration, low blood pressure, or are on a restricted-salt or high-potassium diet.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, low blood pressure (hypotension), fatigue, headache, mild gastrointestinal discomfort (nausea, diarrhea), or cough.
• Hyperkalemia (high blood potassium) is a potentially serious adverse effect and may present with muscle weakness, fatigue, irregular heartbeat, or palpitations. Seek immediate medical attention if these occur.
• Less common side effects can include kidney function changes, increased creatinine, or hormonal-related effects. Your doctor will monitor blood tests to detect these early.
• Allergic reactions such as rash, itching, swelling of the face or tongue, or difficulty breathing are rare but require urgent medical attention.
• If you experience any unusual symptoms, severe dizziness, fainting, chest pain, or signs of electrolyte imbalance, contact your doctor or emergency services immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Strength: 50 mg eplerenone per film-coated tablet.
• Count: 20 film-coated tablets per pack.
• Form: Oral tablet for systemic cardiovascular therapy.
• Intended use: Adult prescription medicine for heart failure and post-myocardial infarction management as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.